Papers
10
Total Citations
780
H-Index
8
About
Claudio Ricci is a leading figure in the field of hepatopancreatobiliary surgery, with a primary research focus on the oncological safety and comparative effectiveness of minimally invasive techniques for pancreatic cancer. His major contributions center on high-impact, multicenter trials and systematic reviews that rigorously compare open, laparoscopic, and robotic approaches for distal pancreatectomy and pancreaticoduodenectomy. As a key investigator in the landmark DIPLOMA trial (2017, 280 citations) and its subsequent international randomized non-inferiority trial (2023, 121 citations), Ricci has provided crucial evidence on oncological outcomes for minimally invasive distal pancreatectomy in pancreatic ductal adenocarcinoma. His work also extends to cost-effectiveness and quality-of-life analyses (2020, 67 citations), as well as benchmarking studies (2022, 29 citations) that define best achievable outcomes. With over 800 total citations across his most-cited papers, Ricci’s research has shaped clinical guidelines and surgical decision-making. His comprehensive network meta-analyses and systematic reviews, including a 2025 meta-analysis of randomized controlled trials on minimally invasive pancreatoduodenectomy, continue to push the boundaries of evidence-based surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotic <i>versus</i> laparoscopic distal pancreatectomy: multicentre analysis121 citations · 2021
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10